| Nr. | Year OPEN | Title | users say | rate good | rate bad | no link | Citation |
|---|
Subarachnoid hemorrhageCoronary heart disease (Takotsubo s syndrome)Intracerebral bleedingCNS (SPECT)Sodium (Hyponatriemia)EndothelinClazosentanStatin| 1 | 2006 | Subarachnoid haemorrhage. | 
| + | - | nl | BMJ 333(7561):235-40 (2006) |
| 2 | 2009 | The warnings of subarachnoid hemorrhage. |
| + | - | nl | South Med J 102(1):8 (2009) |
| 3 | 2007 | Aneurysmal subarachnoid haemorrhage and the anaesthetist. |
| + | - | nl | Br J Anaesth 99(1):102-18 (2007) |
| 4 | 2005 | Trends in monitoring patients with aneurysmal subarachnoid haemorrhage. |
| + | - | nl | Br J Anaesth 94(3):259-70 (2005) |
| 5 | 1995 | Perioperative management of aneurysmal subarachnoid hemorrhage: Part 1. Operative management. |
| + | - | nl | Anesth Analg 81(5):1060-72 (1995) |
| 6 | 1995 | Perioperative management of aneurysmal subarachnoid hemorrhage: Part 2. Postoperative management. |
| + | - | nl | Anesth Analg 81(6):1295-302 (1995) |
| 7 | 2005 | Best evidence topic report. Antifibrinolytics for the initial management of sub arachnoid haemorrhage. |
| + | - | nl | Emerg Med J 22(4):274-5 (2005) |
| 8 | 2006 | Mechanisms of early brain injury after subarachnoid hemorrhage. |
| + | - | nl | J Cereb Blood Flow Metab 26(11):1341-53 (2006) |
| 9 | 2006 | Bilirubin oxidation products (BOXes) and their role in cerebral vasospasm after subarachnoid hemorrhage. |
| + | - | nl | J Cereb Blood Flow Metab 26(10):1223-33 (2006) |
| 10 | 1991 | Haemodynamic considerations in the management of patients with subarachnoid haemorrhage. |
| + | - | nl | Can J Anaesth 38(4 Pt 1):454-70 (1991) |
| 11 | 2006 | Mechanisms of vascular dysfunction after subarachnoid hemorrhage. |
| + | - | nl | J Physiol Pharmacol 57 Suppl 11(-):145-60 (2006) |
| 12 | 2010 | Randomized, double-blind, placebo-controlled, pilot trial of high-dose methylprednisolone in aneurysmal subarachnoid hemorrhage. |
| + | - | nl | J Neurosurg 112(3):681-8 (2010) |
| 13 | 2009 | Simvastatin for the prevention of symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage: a single-institution prospective cohort study. |
| + | - | nl | J Neurosurg 110(5):968-74 (2009) |
| 14 | 2008 | Spontaneous isolated convexity subarachnoid hemorrhage: presentation, radiological findings, differential diagnosis, and clinical course. |
| + | - | nl | J Neurosurg 109(6):1034-41 (2008) |
| 15 | 2006 | Tako-tsubo cardiomyopathy in aneurysmal subarachnoid hemorrhage: an underappreciated ventricular dysfunction. | 
| + | - | nl | J Neurosurg 105(2):264-70 (2006) |
| 16 | 2001 | Subarachnoid haemorrhage: diagnosis, causes and management. |
| + | - | nl | Brain 124(Pt 2):249-78 (2001) |
| 17 | 1993 | Management of subarachnoid haemorrhage. |
| + | - | nl | J Neurol Neurosurg Psychiatry 56(9):947-59 (1993) |
| 18 | 1990 | The diagnosis of subarachnoid haemorrhage. |
| + | - | nl | J Neurol Neurosurg Psychiatry 53(5):365-72 (1990) |
| 19 | 2005 | Subarachnoid hemorrhage: neurointensive care and aneurysm repair. |
| + | - | nl | Mayo Clin Proc 80(4):550-9 (2005) |
| 20 | 2006 | Randomized controlled trial of acetylsalicylic acid in aneurysmal subarachnoid hemorrhage: the MASH Study. |
| + | - | nl | Stroke 37(9):2326-30 (2006) |
| 21 | 2005 | Risk factors for subarachnoid hemorrhage: an updated systematic review of epidemiological studies. |
| + | - | nl | Stroke 36(12):2773-80 (2005) |
| 22 | 2003 | Editorial comment--Spontaneous subarachnoid hemorrhage: volume, experience, and outcome. |
| + | - | nl | Stroke 34(9):2206-7 (2003) Matz PG |
| 23 | 2003 | Antifibrinolytic therapy for aneurysmal subarachnoid hemorrhage: a major update of a cochrane review. |
| + | - | nl | Stroke 34(9):2308-9 (2003) |
| 24 | 2003 | Antiplatelet therapy in aneurysmal subarachnoid hemorrhage: a systematic review. |
| + | - | nl | Stroke 34(9):2285-9 (2003) |
| 25 | 1996 | Risk factors for subarachnoid hemorrhage: a systematic review. |
| + | - | nl | Stroke 27(3):544-9 (1996) |
| 26 | 1993 | Subarachnoid hemorrhage without detectable aneurysm. A review of the causes. |
| + | - | nl | Stroke 24(9):1403-9 (1993) |
| 27 | 1985 | Risk factors for subarachnoid hemorrhage. |
| + | - | nl | Stroke 16(3):377-85 (1985) |
| 28 | 1989 | Pathophysiology of acute intracerebral and subarachnoid hemorrhage: applications to MR imaging. |
| + | - | nl | AJR Am J Roentgenol 153(1):135-9 (1989) |
| 29 | 1998 | SPECT imaging in cerebral vasospasm following subarachnoid hemorrhage. |
| + | - | nl | J Nucl Med 39(5):765-9 (1998) |
| 30 | 2007 | Death by nondiagnosis: why emergent CT angiography should not be done for patients with subarachnoid hemorrhage. |
| + | - | nl | AJNR Am J Neuroradiol 28(10):1837-8 (2007) |
| 31 | 2007 | Safety and feasibility of intra-arterial nicardipine for the treatment of subarachnoid hemorrhage-associated vasospasm: initial clinical experience with high-dose infusions. |
| + | - | nl | AJNR Am J Neuroradiol 28(5):844-8 (2007) |
| 32 | 2004 | Fluid-attenuated inversion recovery MR imaging and subarachnoid hemorrhage: not a panacea. |
| + | - | nl | AJNR Am J Neuroradiol 25(4):545-50 (2004) |
| 33 | 2001 | Mechanical and pharmacologic treatment of vasospasm. |
| + | - | nl | AJNR Am J Neuroradiol 22(8 Suppl):S26-7 (2001) |
| 34 | 1997 | A practical approach to the treatment of vasospasm. |
| + | - | nl | AJNR Am J Neuroradiol 18(9):1653-60 (1997) |
| 35 | 2010 | Isolated acute nontraumatic cortical subarachnoid hemorrhage. |
| + | - | nl | AJNR Am J Neuroradiol 31(8):1355-62 (2010) |
| 36 | 2006 | Hyponatremia and cerebrovascular spasm in aneurysmal subarachnoid hemorrhage. |
| + | - | nl | Neurol India 54(3):273-5 (2006) Chandy D |
| 37 | 2010 | Cognitive and functional outcome after aneurysmal subarachnoid hemorrhage. |
| + | - | nl | Stroke 41(8):e519-36 (2010) |
| 38 | 2010 | Neuroprotection in subarachnoid hemorrhage. |
| + | - | nl | Stroke 41(10 Suppl):S79-84 (2010) |
| 39 | 2008 | Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial. | 
| + | - | nl | Stroke 39(11):3015-21 (2008) |
| 40 | 2010 | Effect of statin treatment on vasospasm, delayed cerebral ischemia, and functional outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis update. |
| + | - | nl | Stroke 41(1):e47-52 (2010) |
| 41 | 2010 | 'Yes' or 'no' to routine statins after subarachnoid hemorrhage to prevent delayed cerebral ischaemia, vasospasm, and death? A cautionary tale of 2 meta-analyses. |
| + | - | nl | Stroke 41(1):e1-2 (2010) Sandercock P |
| 42 | 2011 | Intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage: an updated systemic review and meta-analysis. |
| + | - | nl | Crit Care 15(1):R52 (2011) |
| 43 | 2010 | Hypertension may be the most important component of hyperdynamic therapy in cerebral vasospasm. |
| + | - | nl | Crit Care 14(3):151 (2010) |
| 44 | 2010 | Effect of different components of triple-H therapy on cerebral perfusion in patients with aneurysmal subarachnoid haemorrhage: a systematic review. |
| + | - | nl | Crit Care 14(1):R23 (2010) |
| 45 | 2007 | Clinical review: Prevention and therapy of vasospasm in subarachnoid hemorrhage. |
| + | - | nl | Crit Care 11(4):220 (2007) |
